Filtered By:
Source: CardioBrief
This page shows you your search results in order of date. This is page number 17.
Order by Relevance | Date
Total 307 results found since Jan 2013.
Observational Study Lends Support to CRT Guidelines
A large observational study published in JAMA suggests that patients with left bundle-branch block (LBBB) and longer QRS duration derive the most benefit from a cardiac resynchronization therapy defibrillator (CRT-D). The findings appear to support current, but often criticized, guidelines from the American College of Cardiology, American Heart Association, and the Heart Rhythm Society, in which a class I recommendation is restricted to patients with LBBB and QRS duration of 150 ms or greater. Click here to read the full post on Forbes.
Source: CardioBrief - August 13, 2013 Category: Cardiology Authors: Larry Husten Tags: Heart Rhythms American College of Cardiology american heart association CRT-D guidelines Heart Rhythm Society JAMA Left bundle branch block Observational study pacemakers QRS complex Source Type: blogs
The Guidelines Are Dead. Long Live The Guidelines.
Following last month’s surprising announcement that the National Heart, Lung, and Blood Institute would no longer issue guidelines, leaders of the American Heart Association and the American College of Cardiology have now announced that are “officially assuming the joint governance, management and public distribution” of the enormously influential cardiovascular prevention guidelines, including the much-delayed and much-anticipated hypertension and cholesterol guidelines (formerly known as JNC 8 and ATP IV). The ACC and AHA will also assume responsibility for guidelines on cardiovascular risk asses...
Source: CardioBrief - August 9, 2013 Category: Cardiology Authors: Larry Husten Tags: People, Places & Events Policy & Ethics Prevention, Epidemiology & Outcomes American College of Cardiology american heart association cholesterol hypertension national heart lung and blood institute Source Type: blogs
European Heart Guidelines Based On Disgraced Research May Have Caused Thousands Of Deaths
Despite a 2-year-old scandal discrediting key evidence, current guidelines relying on this evidence have not been revised. As a result of physicians following these guidelines, some researchers say, it is possible that thousands of patients may have died each year in the UK alone. It is unlikely that a true understanding of the damage will ever be known. Current European Society of Cardiology guidelines recommend that beta-blockers be given to many patients having surgery for noncardiac reasons to protect the heart during surgery. (US guidelines are somewhat less aggressive in their endorsement of perioperative beta-bloc...
Source: CardioBrief - July 31, 2013 Category: Cardiology Authors: Larry Husten Tags: Interventional Cardiology & Surgery Policy & Ethics Prevention, Epidemiology & Outcomes Beta blocker European Society of Cardiology Guideline Heart disease medicine perioperative beta-blockade Source Type: blogs
Sex And The Cardiac Patient Should Not Be A Taboo Subject
It’s not an easy conversation to have. After a heart attack or other major cardiac event, talking about sex is awkward, and often avoided by patients, their partners, and physicians. But a new consensus statement from several major cardiology organizations urges physicians to get over their reluctance or embarrassment and counsel their cardiac patients about this important, but often neglected, aspect of their lives. After a patient has a heart attack, stroke, cardiac surgery, cardiac device implantation, or is newly diagnosed with a cardiovascular condition, physicians and other healthcare professionals should pro...
Source: CardioBrief - July 29, 2013 Category: Cardiology Authors: Larry Husten Tags: Policy & Ethics Prevention, Epidemiology & Outcomes american heart association European Heart Journal European Society of Cardiology Heart disease myocardial infarction sex Source Type: blogs
Cardiology Goes Better With Coke
At the bottom of this post I’ve reprinted an email cardiologists are receiving from the American College of Cardiology. See the bottom of the message for the disclosure that Coca Cola is paying for this educational program. I don’t have much to say about this though I wonder what the faculty of this program will say about the role of sugared soda and obesity. I also wonder what position the ACC will take on public health efforts to curb sugar consumption. There’s no reason to be surprised about this. Last year the president of the ACC More…
Source: CardioBrief - July 23, 2013 Category: Cardiology Authors: Larry Husten Tags: Policy & Ethics Prevention, Epidemiology & Outcomes American College of Cardiology american heart association Coca Cola diabetes national heart lung and blood institute obesity soda sugar Source Type: blogs
A Glimpse Of The Future Of Cardiology, Including Star Wars Holograms
Goodbye flat images. Hello holography. Sometime in the not-too-far-distant future cardiologists may work with projected 3D holograms of the heart instead of images on a flat screen. And this is just the beginning of a technology-driven transformation of cardiology. That’s the vision of Mount Sinai’s Partho Sengupta, who delivered a widely praised technology-gone-wild lecture at the annual meeting of the American Society of Echocardiography last month. The Feigenbaum lecture featured holograms of projected 3D digital images and animation to demonstrate, according to a Mt. Sinai press release, “the lates...
Source: CardioBrief - July 17, 2013 Category: Cardiology Authors: Larry Husten Tags: People, Places & Events American Society of Echocardiography Holography Mayo Clinic Mount Sinai technology Source Type: blogs
Medtronic Faces Removal Of CoreValve Transcatheter Heart Valve From German Market
In the wake of a major patent decision, Medtronic will be forced to remove its CoreValve transcatheter heart valve from the German market. Edwards Lifesciences said today that a German Court had found that Medtronic infringed a key patent, known as the Spenser patent, and granted an injunction prohibiting the sale of CoreValve and CoreValve Evolut systems in Germany. Medtronic said it would appeal the decision and said the action “will limit options for physicians and their patients who need transcatheter aortic valve procedures, which Medtronic believes is contrary to sound health policy.” … C...
Source: CardioBrief - July 12, 2013 Category: Cardiology Authors: Larry Husten Tags: Interventional Cardiology & Surgery People, Places & Events Policy & Ethics Aortic valve CoreValve Edward Lifesciences Edwards Lifesciences Corporation Germany Medtronic Patent Source Type: blogs
‘A Plane Just Crashed At SFO!’
A young cardiology fellow was on duty last Saturday at San Francisco General Hospital when the director of the cath lab came running into the room: “A plane just crashed at SFO!” Payal Kohli tells her story about that day, and reflects on its meaning, on CardioExchange (a cardiology website published by the New England Journal of Medicine). Here are a few excerpts: No one really knew what to expect at SFGH, the main trauma center in SF and the closest hospital to the airport. But, within a matter of minutes, we were already functioning in full More…
Source: CardioBrief - July 10, 2013 Category: Cardiology Authors: Larry Husten Tags: People, Places & Events Policy & Ethics disaster medicine San Francisco General Hospital San Francisco International Airport Source Type: blogs
Paper Raises Hundreds Of Questions About The Integrity Of Stem Cell Research Group
Serious questions have been raised about the integrity and validity of research performed by a well-established German stem cell research group. A paper published in the International Journal of Cardiology exhaustively details a multitude of discrepancies and contradictions in papers from the researcher’s group. Further, the revelation of such widespread misconduct may lead to broader disturbing questions about the reliability of scientific publications and the ability of the clinical research system to police itself. In “Autologous bone marrow-derived stem cell therapy in heart disease: Discrepancies and co...
Source: CardioBrief - July 2, 2013 Category: Cardiology Authors: Larry Husten Tags: People, Places & Events Policy & Ethics Clinical trial European Society of Cardiology International Journal of Cardiology medicine scientific misconduct Stem cell Source Type: blogs
Hypertension And Cholesterol Guidelines Delayed Again As NHLBI Gets Out Of The Guidelines Business
The National Heart, Lung, and Blood Institute (NHLBI) will no longer issue guidelines, including the much-delayed and much-anticipated hypertension (JNC 8) and cholesterol (ATP IV) guidelines. Instead, the NHLBI will perform systematic evidence reviews that other organizations, including the American Heart Association and the American College of Cardiology, will use as a resource for their own guidelines. The exact fate and form of the delayed hypertension and cholesterol guidelines has not yet been decided, though the NHLBI’s Michael Lauer said he was confident that these guidelines would appear in less than a yea...
Source: CardioBrief - June 19, 2013 Category: Cardiology Authors: Larry Husten Tags: Policy & Ethics Prevention, Epidemiology & Outcomes American College of Cardiology american heart association cholesterol guidelines health hypertension national heart lung and blood institute NHLBI Source Type: blogs
Top Line Results: No Cardiovascular Benefits Found For Saxagliptin
Top line results of a large phase 4 study with saxagliptin (Onglyza, Bristol-Myers Squibb and AstraZeneca) demonstrate that the drug is safe but has no cardiovascular benefits. AstraZeneca and Bristol-Myers Squibb today announced the top line results for the SAVOR-TIMI-53 Cardiovascular Outcomes Trial of Onglyza®. The full results are scheduled to presented at the annual meeting of the European Society of Cardiology in Amsterdam on September 2 by Deepak Bhatt. … Click here to read the full story on Forbes.
Source: CardioBrief - June 19, 2013 Category: Cardiology Authors: Larry Husten Tags: Policy & Ethics Prevention, Epidemiology & Outcomes AstraZeneca Bristol Myers Squibb Dipeptidyl peptidase-4 inhibitor European Society of Cardiology food and drug administration Onglyza Saxagliptin Source Type: blogs
Hot Line Trials For European Society Of Cardiology Congress Announced
The European Society of Cardiology has published the full program for the 2013 Congress taking place in Amsterdam from August 31 through September 4. There will be 4 Hot Line Sessions. Here is the schedule for Hot Line trials: … Click here to read the full post on Forbes.
Source: CardioBrief - June 18, 2013 Category: Cardiology Authors: Larry Husten Tags: People, Places & Events Amsterdam Cardiology clinical trials European Society of Cardiology Source Type: blogs
New European Hypertension Guidelines Released With Simplified Blood Pressure Target
New hypertension guidelines from the European Society of Hypertension and the European Society of Cardiology were released in Milan today at the European Meeting on Hypertension & Cardiovascular Protection. The authors of the guidelines write that “despite overwhelming evidence that hypertension is a major cardiovascular risk, studies show that many are still unaware of the condition, that target blood pressure levels are seldom achieved”. They report that hypertension affects 30-45% of people in Europe. Perhaps the biggest single change in the new document is the adoption of a single systolic blood pressure targ...
Source: CardioBrief - June 14, 2013 Category: Cardiology Authors: Larry Husten Tags: Policy & Ethics Prevention, Epidemiology & Outcomes blood pressure European Society of Cardiology European Society of Hypertension Source Type: blogs
New Trend? Free Tablet Computers For All Registrants At TCT Meeting
Cardiologists and others who attend this year’s TCT meeting in San Francisco will receive a free tablet computer. TCT is the highly influential interventional cardiology meeting run by the Cardiovascular Research Foundation. This year it will take place in San Francisco from October 27 through November 1. Heavily promoted in emails and on the site’s webpage, TCT is promising that paid registrants for the entire meeting “will receive a free tablet computer loaded with the official conference app and other interactive tools to optimize the TCT experience.” Attendees will get to keep their tablet...
Source: CardioBrief - June 13, 2013 Category: Cardiology Authors: Larry Husten Tags: People, Places & Events Policy & Ethics Cardiology Facebook interventional cardiology RFID Tablet computer Source Type: blogs
People With Sleep Apnea At Increased Risk For Sudden Cardiac Death
Although people with obstructive sleep apnea (OSA) have an increased risk for death and cardiovascular disease, the relationship between OSA and sudden cardiac death (SCD) has not been clear. Now a new study published in the Journal of the American College of Cardiology provides evidence that OSA is in fact associated with an increase in the risk for SCD. Click here to read the full post in Forbes.
Source: CardioBrief - June 11, 2013 Category: Cardiology Authors: Larry Husten Tags: Heart Rhythms Prevention, Epidemiology & Outcomes obstructive sleep apnea Sleep disorder sudden cardiac death Source Type: blogs
